ARID1A and cholangiocarcinoma: To address the clinical impact of ARID1A mutations in CCA with different etiologies and clinicopathological features, we performed a systemic analysis of mutational data of ARID1A from previous whole genome/exome and targeted sequencing data of 489 CCA (Jusakul et al., 2017) and evaluated the correlation with clinicopathological features.